Lipoprotein(a) [Lp(a)] has emerged as an independent contributor to residual atherosclerotic cardiovascular risk. However, its association with angiographic disease burden among patients undergoing percutaneous coronary intervention (PCI) remains incompletely characterized.
To evaluate the relationship bet...
P. Theofilis, P. Vlachakis, A. Papanikolaou et al.· European Heart Journal· 0 citations
Coronary microvascular dysfunction (CMD) is a major mechanism of myocardial ischemia and adverse cardiovascular outcomes in patients with angina or dyspnea, both in the absence and in the presence of obstructive coronary artery disease. Because the coronary microcirculation cannot be visualized directly with routine an...
Panagiotis Theofilis, A. Sakalidis, Kyriakos Dimitriadis et al.· Medicina· 0 citations
INTRODUCTION
Transcatheter aortic valve implantation (TAVI) has become an established treatment for severe aortic stenosis across an expanding risk spectrum. As indications extend to younger and lower-risk patients, post-treatment complications with implications for survival, quality of life, and valve durability requi...
Panagiotis Theofilis, P. Vlachakis, George Koutsopoulos et al.· Expert Review of Cardiovascu...· 0 citations
Background/Objectives: Diet quality is a potentially modifiable determinant of heart failure (HF), yet evidence regarding its long-term association with HF incidence remains limited. This study examined the association between baseline diet quality and 20-year incident HF in the population-based ATTICA cohort. Methods:...
C. Chrysohoou, P. Iliakis, I. Daha et al.· Nutrients· 0 citations
In HF patients, atrial shunting provides significant improvement in exercise capacity, quality of life, and hemodynamics, and the absence of clinical benefit necessitates further randomized studies focusing on specific phenotypes in order to optimize patient selection and prove clinical effect.
N. Pyrpyris, Kyriakos Dimitriadis, Eirini Beneki et al.· Cardiology in Review· 0 citations
BACKGROUND
Heart failure (HF) remains a significant challenge in global healthcare, contributing to frequent hospitalizations and elevated mortality rates. Cardiopulmonary exercise testing (CPET) provides a non-invasive method of assessing how the cardiovascular, respiratory, and musculoskeletal systems function.
OBJ...
Christina Chrysohoou, M. Dulay, C. Fragoulis et al.· Heart & lung : the journal o...· 0 citations
A comprehensive overview of emerging pharmacologic and interventional approaches for BP management in nondialysis CKD is provided, highlighting mechanism-driven innovations and their potential clinical translation.
A. Damianaki, P. Iliakis, A. Vakka et al.· Journal of Hypertension· 0 citations
Why injectable lipid-lowering therapies in advanced CKD merits serious consideration is highlighted - not only for their potent and durable lipid-lowering effects, but also for their ability to target other paths that contribute to the excess CV risk not captured by LDL alone.
A. Damianaki, E. Stambolliu, P. Iliakis et al.· Cardiovascular Drugs and The...· 0 citations
This review outlines the expanding role of echocardiography across the spectrum of TSHIs, highlighting the importance of multimodality imaging, including three-dimensional transoesophageal echocardiography (3D TEE), intracardiac echocardiography (ICE) and fusion imaging techniques, for comprehensive structural evaluati...
N. Ktenopoulos, K. Vlasopoulou, P. Vlachakis et al.· European heart journal. Imag...· 0 citations
A better understanding of CKD-CM pathogenesis is likely to enable early intervention and prevention, with successful outcomes measured by reduced progression to severe cardiomyopathy and lower cardiovascular mortality in CKD.
Konstantinos Grigoriou, Vasileios Lamprou, Anastasios Chatzichidiroglou et al.· British journal of hospital...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
